Highest-materiality recent filing
Global Asset Management acquires 83.125% interest in Memorial Real Estate Group for $6.455M
Total consideration: $6M 1-year convertible note (6% simple interest) plus $455k cash; note convertible at 90% of 30-day VWAP after Oct 8, 2026.
Facility: $10M purchase price, $10.81M principal with OID; senior secured, convertible at $0.95 fixed price.
Acquired 100% of SCG, SP, ST1, ST2, and TMD for 35,780,924 shares of common stock.
Global Asset Management completes acquisition of DC Rental Portfolio for 250M shares
Acquired 100% of DC Rental Portfolio Corp. in exchange for 250,000,000 common shares.
GAMG acquires Bella Rio for 450k shares; appoints new CEO, President, CMO, GC
Acquired Bella Rio Marketing Agency for 450k common shares; Bella Rio had $92.8k first-year revenue.
Kenilworth acquires DC Rental in reverse merger; name changes to National Real Estate Ventures
Acquires 100% of DC Rental for 350M shares (91% of post-deal stock); properties appraised at min $100M.
Kenilworth Systems acquires 60% of Regenecell; pivots to medical travel referral
Issued 2M shares (3.8% of outstanding) to acquire 60% of Regenecell, a Florida medical travel consulting firm.
Kenilworth Systems acquires 60% of Regenecell in share exchange; Swank joins board
KENS issued 2M shares to Steven Swank for 600k shares of Regenecell, gaining 60% control.
License grants access to up to 240M data records and 700M categorized records with 300 data field points.
Kenilworth Systems sells principal assets back to ACL Group, extinguishing $300M note
On March 17, 2022, Kenilworth sold its proprietary IP and databases to ACL Group for cancellation of a $300M secured promissory note.
Kenilworth Systems acquires ACL Group IP assets and issues securities; director resigns
Acquired certain intellectual property and database assets of ACL Group, Inc.
Effective July 24, 2026, the Board of Directors accepted the resignation of Daniel Snyder as a Director of the Issuer pursuant to his retirement request, effective immediately.
Effective July 24, 2026, the Board of Directors appointed David Marshall Nissman to the Board of Directors of the Issuer.
On September 30, 2023, Steven Swank was appointed as a Director and Secretary of the Company following the acquisition by the Company of a 60% controlling interest in Regenecell, Inc., a Company of which Mr. Swank was the President and Founder.
On March 29, 2023, Neil Kleinman resigned as a Director and Officer of the Company, effective immediately.
On January 7, 2022, Dan Snyder resigned as a Director of the Company, effective immediately.
the Board appointed Neil Kleinman as a Director and as President/CEO of the Company.
On September 30, 2021, Peter Zompa resigned as a Director of the Company, effective immediately.
Max materiality 1.00 · Median 0.60 · Most common event m_and_a